MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Cocaine

Selected References:

  • Ackerman JP, et al. 2010. A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics 125(3):554-565.  
  • Akyuz N, et al. 2014. Structural brain imaging in children and adolescents following prenatal cocaine exposure: preliminary longitudinal findings. Dev Neurosci. 316-28.
  • Behnke M, et al. 2001. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 107(5):E74.
  • Bracken MB, et al. 1990. Association of cocaine use with sperm concentration, motility, and morphology. Fertil Steril 53:315-322
  • British Columbia Reproductive Care Program. 1999. Substance Use Guideline 5B: Prenatal Cocaine Exposure, Care of the Newborn. Retrieved from: www.perinatalservicesbc.ca/Documents/Guidelines-Standards/Newborn/CocaineExposureNewbornCareGuideline.pdf.
  • Cestonari, C, et al. 2022. Infants of mothers with cocaine use: Review of clinical and medico-legal aspects. Children 9(1):67-84.
  • Chiriboga C, et al. 2007. Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior. Neurotoxicol Teratol29: 323-330.
  • Chiriboga CA, et al. 2009. Prenatal cocaine exposure and prolonged focus attention. Poor infant information processing ability or precocious maturation of attentional systems? Dev Neurosci 31(1-2):149-158.
  • Cone EJ, et al. 1996. Cocaine excretion in the semen of drug users. J Anal Toxicol 20:139-140.
  • De Genna, N. M., Goldschmidt, L., & Richardson, G. A. (2022). Prenatal cocaine exposure, early cannabis use, and risky sexual behavior at age 25. Neurotoxicology and teratology, 89, 107060. https://doi.org/10.1016/j.ntt.2021.107060
  • Dos Santos JF, et al. 2018. Maternal, fetal and neonatal consequences associated with the use of crack cocaine during the gestational period: a systematic review and meta-analysis. Arch Gynecol Obstet. 298(3):487-503.
  • Hoyme HE, et al. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747.
  • Jufer RA, et al. 2000. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. Journal of analytical toxicology; 24(7), 467–477.
  • Karpova N, 2021. Prenatal drug exposure and executive function in early adolescence. Neurotoxicology and teratology; 88, 107036.
  • Landi N, et al. 2017. Prenatal Cocaine Exposure Impacts Language and Reading Into Late Adolescence: Behavioral and ERP Evidence. Dev Neuropsychol. 42(6):369-386.
  • Levine TP, et al. 2008. Effects of prenatal cocaine exposure on special education in school-aged children. Pediatrics 122 (1): e83-91.
  • Lewis BA, et al. 2007. Prenatal cocaine and tobacco effects on children’s language trajectories. Pediatrics 120(1):e78-85.
  • Mayer LC, Nicholls S. 2007. Neurocognitive development in middle-school age and adolescent prenatally cocaine-exposed children. Birth Def Res (Part A) 79:381-394.
  • Modernel XD, et al. 2017. Use of crack in pregnancy: repercussions for the newborn.Invest Educ Enferm. 35(3).
  • Montgomery DP, et al. 2008. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. J Perinatol 28(11):750-753.
  • Morie KP, et al. 2020. Alexithymia, Emotion-Regulation Strategies, and Traumatic Experiences in Prenatally Cocaine-Exposed Young Adults. The American journal on addictions; 29(6), 492–499.
  • Ness RB, et al. 1999. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl Med 340(5):333-339.s
  • Oliveira TA, et al. 2016. Perinatal outcomes in pregnant women users of illegal drugs. Rev Bras Ginecol Obstet. 38(4):183-188.
  • Pires A, et al 2012. Repeated inhalation of crack-cocaine affects spermatogenesis in young and adult mice. Inhal Toxicol. 24(7):439-446.
  • Reece-Stremtan S, Marinelli KA. 2015. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med. 10(3):135-41.
  • Richardson GA, et al. 2007.Effects of prenatal cocaine exposure on growth: a longitudinal analysis. Pediatrics. 120(4): e1017-1027.
  • Richardson GA, et al. 2010. Prenatal cocaine exposure: Effects on mother- and teacher-rated behavior problems and growth in school-age children. Neurotoxicol Teratol.
  • Richardson GA, et al. 2015. Effects of prenatal cocaine exposure on adolescent development. Neurotoxicol Teratol. 49:41-8.
  • Roussotte F, et al. 2010. Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging. Neuropsychol Rev.
  • Salzwedel A, et al. 2020. Functional dissection of prenatal drug effects on baby brain and behavioral development. Human brain mapping; 41(17), 4789–4803.
  • Semet M, et al. 2017. The impact of drugs on male fertility: a review. Andrology 5:640-63.
  • Serino D, et al. 2018. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood. J Dual Diagn. 25:1-13.
  • Singer LT, et al. 2000. Neurobehavioral outcomes of cocaine-exposed infant. Neurotoxical Teratol 22(5):653-666.
  • Singer LM, et al. 2008. Prenatal cocaine exposure: drug and environmental effects at 9 years. J Pediatr 153(1): 105-111.
  • Van Gelder MMHJ, et al. 2009. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology 20(1):60-66.
  • Weathers WT, et al. 1993. Cocaine use in women from a defined population: prevalence at delivery and effects of growth in infants. Pediatrics 91(2):326-239.
  • Yazigi RA, et al. 1991. Demonstration of specific binding of cocaine to human spermatozoa. JAMA 266:1956-1959. 

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.